Autologous iPSC-derived cardiac lineage cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous iPSC-derived cardiac lineage cells, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease [Phase 1]